You are here » Home » Companies » Company Overview » Parabolic Drugs Ltd

Parabolic Drugs Ltd.

BSE: 533211 Sector: Health care
NSE: PARABDRUGS ISIN Code: INE618H01016
BSE 00:00 | 25 Jan Parabolic Drugs Ltd
NSE 05:30 | 01 Jan Parabolic Drugs Ltd
OPEN 5.70
PREVIOUS CLOSE 5.70
VOLUME 21
52-Week high 6.96
52-Week low 2.05
P/E
Mkt Cap.(Rs cr) 35
Buy Price 6.35
Buy Qty 1649.00
Sell Price 5.70
Sell Qty 56019.00
OPEN 5.70
CLOSE 5.70
VOLUME 21
52-Week high 6.96
52-Week low 2.05
P/E
Mkt Cap.(Rs cr) 35
Buy Price 6.35
Buy Qty 1649.00
Sell Price 5.70
Sell Qty 56019.00
Filter:

Parabolic Drugs Ltd. (PARABDRUGS) - Profit And Loss

Figures in Rs crore 2018 2017 2016
Income
Sales Turnover 72.60 73.72 84.47
Excise Duty 0.00 0.00 8.88
Net Sales 72.60 73.72 75.59
Other Income 4.11 4.25 0.31
Stock Adjustments 0.73 -27.87 -270.31
Total Income 77.44 50.10 -194.41
Expenditure
Raw Materials 64.16 64.02 58.21
Power & Fuel Cost 6.87 8.97 10.17
Employee Cost 9.30 8.47 10.68
Other Manufacturing Expenses 2.77 3.82 4.21
Selling and Administration Expenses 5.59 5.63 8.50
Miscellaneous Expenses 0.21 0.67 19.91
less: Pre-operative Expenses Capitalised 0.00 0.00 0.00
Total Expenditure 88.90 91.58 111.68
Operating Profit -11.45 -41.46 -306.08
Interest 9.25 10.07 107.62
Gross Profit -20.70 -51.53 -413.70
Depreciation 34.54 53.49 67.06
Profit Before Tax -55.24 -105.02 -480.76
Tax 1.76 3.05 4.43
Net Profit -57.00 -108.07 -485.19
.